See also this year's filing and all EDGAR filings for this company.
PDF Report 0001444192_2023_Acasti_Pharma_Inc.pdf
Logs
Graph
Absolute values for 0001444192, Acasti Pharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 45,531,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 82,774,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 315,000 |
| 4 | LiabilitiesCurrent | 3,260,000 |
| 5 | LiabilitiesNoncurrent | 191,000 |
| 6 | remainder_Liabilities | 16,899,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,263,000 |
| 9 | ResearchAndDevelopmentExpense | 5,559,000 |
| 10 | remainder_Expenses | 119,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 5,122,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 128,620,000 |
| 1 | Liabilities | 20,350,000 |
| 2 | Expenses | 14,941,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 108,270,000 |
| 5 | NetIncome | -9,819,000 |
| 6 | ComprehensiveNetIncome | -9,819,000 |
| 7 | BaseVar | 84,516,500 |
| 8 | EconomicCapitalRatio | 2.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
